Drug Type Small molecule drug |
Synonyms NCX 125, NCX-125 |
Target |
Action agonists, donors |
Mechanism PTGFR agonists(Prostanoid FP receptor agonists), Nitric oxide donors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H38N2O11 |
InChIKeyLHXPWOYQRNXOAU-TXINQBHHSA-N |
CAS Registry860005-99-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glaucoma | Preclinical | United States | 25 Apr 2010 | |
| Glaucoma | Preclinical | Italy | 25 Apr 2010 |





